Tag: Kevin Sayer
Dexcom exec: CGM is ‘undisputed standard of care’
January 13, 2023Tracy Orzel
SAN DIEGO – Dexcom’s next-generation G7 continuous glucose monitoring (CGM) system will empower users to take control of their health, says top company exec Kevin Sayer.
Dexcom in December received clearance from the U.S. Food and Drug Administration for the device, which can be used for people with all types of diabetes ages two years and older.
“The FDA approval of Dexcom G7 is a huge milestone for the diabetes community and underscores continued momentum in...
Continuous Glucose Monitor (CGM), Dexcom, Dexcom G7, Diabetes, Kevin Sayer
Sponsored Stories
SOS Achieves Remarkable 400% Growth in 2023, Bolsters Team with Director Appointment
By Strategic Office SupportCyber Siege: The Financial Vulnerability Healthcare Didn't See Coming
By Strategic Office SupportA new staffing model that delivers ready-to-work pros, boosting efficiency and lowering costs.
By Tactical Back Office
By John Koch, COO and co-founder, MediStreams